Loading...
•
Dec 31, 2020
Enovis Q4 2020 Earnings Report
Colfax reported Q4 2020 results, achieving $0.29 EPS and $0.51 adjusted EPS.
Key Takeaways
Colfax Corporation announced strong Q4 2020 results with net sales of $828 million and adjusted EPS of $0.51. The company also completed the acquisition of two medical technology businesses and provided a positive 2021 growth outlook.
Reported $0.29 EPS from continuing operations and achieved $0.51 of adjusted EPS.
Net sales increased to $828 million, a 3% sequential increase from Q3 2020.
Generated operating cash flow of $129 million and free cash flow of $96 million.
Announced 2021 outlook with expectations for significant revenue, profit, and cash flow growth.
Forward Guidance
Colfax expects significant growth in sales, earnings and cash flow in 2021.
Positive Outlook
- Revenue is expected to grow 15-18% from the prior year.
- Adjusted earnings to grow at least 44% to $2.00 to $2.15 per diluted share.
- Projecting free cash flow of $250 million or more.
- Expects adjusted earnings of $0.35 to $0.40 per diluted share for Q1 2021.
- Sequentially improving throughout the year due to seasonality and expected recovery in customer demand.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...